Effect of adenosine triphosphate on the accessory pathways

Area of Science:

• Cardiology
• Electrophysiology
• Medical Research

Background:

• Wolff-Parkinson-White (WPW) syndrome is characterized by ventricular preexcitation due to accessory pathways.
• Understanding conduction properties of these accessory pathways is crucial for diagnosis and management.

Purpose of the Study:

• To elucidate the sites of anterograde and retrograde conduction in WPW using adenosine triphosphate (ATP).
• To investigate the relationship between ATP's effects and the accessory pathway's effective refractory period (ERP).

Main Methods:

• Electrophysiological studies were conducted in 53 patients with WPW.
• Adenosine triphosphate (ATP) was administered intravenously (40 mg) to assess its impact on accessory pathway conduction.
• Patients were categorized into groups based on whether the accessory pathway was evident or concealed.

Main Results:

• ATP abolished anterograde conduction in 10 of 40 patients with evident accessory pathways.
• Retrograde conduction in the accessory pathway was prolonged or abolished in 7 patients with evident and 4 with concealed pathways.
• A correlation was observed between the Kent effective refractory period (ERP) and ATP's effect; shorter ERPs (<230 ms) showed no change, while longer ERPs (>280 ms) correlated with decreased retrograde conduction.

Conclusions:

• Adenosine triphosphate (ATP) can effectively modulate accessory pathway conduction in WPW syndrome.
• The observed effects of ATP are linked to the accessory pathway's effective refractory period (ERP).
• These findings offer insights into the electrophysiological characteristics of accessory pathways in WPW.